focus
Previous article:
BioMarin wins approval for gene therapy to treat hemophilia A
Next article: The best solution to the drug shortages problem
Next article: The best solution to the drug shortages problem
focus
leisure time
-
Ed Silverman on new gene therapies, biosimilars, coffee, and more
2025-08-20 09:32
-
Amylyx's ALS drug launch starts strong. It could be trouble for FDA
2025-08-20 09:28
-
Emergent cuts jobs, executive role in business shake
2025-08-20 08:58
-
The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio
2025-08-20 08:24
-
FDA panel issues narrow recommendation for Covid vaccine booster doses
2025-08-20 08:15
-
Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement
2025-08-20 07:33

